Cmpk2 Protects Against Acute Lung Injury in Mice
Authors:
- 5 July 2025
- journal article
- research article
- Published by Springer Nature in Lung
- Vol. 203 (1) , 1-10
Abstract
Purpose Acute respiratory distress syndrome (ARDS)/Acute lung injury (ALI), characterized by severe hypoxemia and pulmonary edema, involves mitochondrial dysfunction. Cytidine/uridine monophosphate kinase 2 (Cmpk2), a mitochondrial metabolic enzyme, modulates inflammation and senescence, yet its role in ARDS remains unclear. We investigated Cmpk2’s function in Pseudomonas aeruginosa (P. aeruginosa)-induced ALI using Cmpk2 global knockout (KO) mice. Methods Cmpk2 was identified through mitochondrial gene expression analysis of ARDS datasets (GEO). Murine ALI was induced by intratracheal P. aeruginosa injection. Lung pathology (hematoxylin and eosin staining), leukocyte recruitment (flow cytometry), and cytokines (ELISA) were assessed. GO/KEGG analyses were conducted to identify Cmpk2-associated biological processes and pathways. The expression of Cmpk2 in leukocyte populations was analyzed using single-cell RNA sequencing (scRNA-seq) data from ARDS patient samples. Mouse neutrophils’ phagocytosis of P. aeruginosa was quantified by flow cytometry. Zebrafish embryos were infected with P. aeruginosa and Staphylococcus aureus for bacterial burden and survival assays. Results Cmpk2 expression was significantly upregulated in ARDS. Cmpk2 KO exacerbated P. aeruginosa-induced ALI in mice, as evidenced by increased pathological damage and permeability, elevated proinflammatory cytokines and enhanced neutrophil infiltration. GO/KEGG analyses linked Cmpk2 to innate immunity. scRNA-seq analysis revealed an enriched expression of Cmpk2 in neutrophils. Cmpk2 deficiency impaired neutrophil phagocytosis and reduced host survival during bacterial infection, accomplished by decreased STING expression. The differences in phagocytosis between the wild-type and Cmpk2 KO mouse neutrophils/zebrafish embryos were eliminated by STING inhibitor C176. Conclusion Cmpk2 protects against pneumonia by attenuating neutrophil recruitment and enhancing bacterial phagocytosis via STNG-dependent mechanisms.Keywords
Funding Information
- Key Project of Chongqing Technological Innovation and Application Development Special Project (CSTC2021jscx-gksb-N0028)
- National Natural Science Foundation of China (32170766)
- National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai (NRCTM(SH)-2025-08)
This publication has 34 references indexed in Scilit:
- Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategiesMedcomm, 2025
- The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearanceImmunity, 2024
- Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDSBiomedicine & Pharmacotherapy, 2024
- Dracorhodin targeting CMPK2 attenuates inflammation: A novel approach to sepsis therapyClinical and Translational Medicine, 2023
- Deletion of G protein-coupled receptor 116 enhances neutrophil function and aggravates lung injury in miceGenes & Diseases, 2023
- HDAC3 deficiency protects against acute lung injury by maintaining epithelial barrier integrity through preserving mitochondrial quality controlRedox Biology, 2023
- Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signalingImmunity, 2022
- Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammationImmunity, 2021
- Mitochondrial CMPK2 mediates immunomodulatory and antiviral activities through IFN-dependent and IFN-independent pathwaysiScience, 2021
- CMPK2 of triploid crucian carp is involved in immune defense against bacterial infectionDevelopmental & Comparative Immunology, 2021